JP2023536633A - ヘテロアリール及びヘテロシクリル化合物 - Google Patents

ヘテロアリール及びヘテロシクリル化合物 Download PDF

Info

Publication number
JP2023536633A
JP2023536633A JP2023507667A JP2023507667A JP2023536633A JP 2023536633 A JP2023536633 A JP 2023536633A JP 2023507667 A JP2023507667 A JP 2023507667A JP 2023507667 A JP2023507667 A JP 2023507667A JP 2023536633 A JP2023536633 A JP 2023536633A
Authority
JP
Japan
Prior art keywords
compound
alkyl
heteroalkyl
formula
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023507667A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023536633A5 (cg-RX-API-DMAC10.html
Inventor
リチャード ハイデブレヒト,
クリストファー, ピー. ヘンケン,
パオリス, オマール デ
ウェイヘン ワン,
マシュー ブキャナン,
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigilon Therapeutics Inc
Original Assignee
Sigilon Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigilon Therapeutics Inc filed Critical Sigilon Therapeutics Inc
Publication of JP2023536633A publication Critical patent/JP2023536633A/ja
Publication of JP2023536633A5 publication Critical patent/JP2023536633A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/541—Non-condensed thiazines containing further heterocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP2023507667A 2020-08-04 2021-08-04 ヘテロアリール及びヘテロシクリル化合物 Pending JP2023536633A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063060968P 2020-08-04 2020-08-04
US63/060,968 2020-08-04
PCT/US2021/044564 WO2022031862A2 (en) 2020-08-04 2021-08-04 Heteroaryl and heterocyclyl compounds

Publications (2)

Publication Number Publication Date
JP2023536633A true JP2023536633A (ja) 2023-08-28
JP2023536633A5 JP2023536633A5 (cg-RX-API-DMAC10.html) 2024-08-14

Family

ID=80120142

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023507667A Pending JP2023536633A (ja) 2020-08-04 2021-08-04 ヘテロアリール及びヘテロシクリル化合物

Country Status (9)

Country Link
US (1) US20230303502A1 (cg-RX-API-DMAC10.html)
EP (1) EP4192468A4 (cg-RX-API-DMAC10.html)
JP (1) JP2023536633A (cg-RX-API-DMAC10.html)
KR (1) KR20230048523A (cg-RX-API-DMAC10.html)
CN (1) CN116322777A (cg-RX-API-DMAC10.html)
AU (1) AU2021321433A1 (cg-RX-API-DMAC10.html)
BR (1) BR112023002132A2 (cg-RX-API-DMAC10.html)
CA (1) CA3190778A1 (cg-RX-API-DMAC10.html)
WO (1) WO2022031862A2 (cg-RX-API-DMAC10.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4531879A1 (en) 2022-05-25 2025-04-09 Flagship Pioneering Innovations VI, LLC Compositions of secretory and/or catalytic cells and methods using the same
JP2025520113A (ja) 2022-06-03 2025-07-01 フラッグシップ パイオニアリング イノベーションズ シックス,エルエルシー 組成物及び方法
IL328729A (en) 2023-12-01 2026-07-01 Sigilon Therapeutics Inc Methods for producing stem cell-derived islet-like cells, as well as populations and compositions comprising them

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012514009A (ja) * 2008-12-31 2012-06-21 アーデリクス,インコーポレーテッド 体液貯留または塩分過負荷と関連する障害および消化管障害の治療におけるnhe媒介性アンチポートを阻害するための組成物および方法
WO2016071856A1 (en) * 2014-11-06 2016-05-12 Novartis Ag Amatoxin derivatives and conjugates thereof as inhibitors of rna polymerase
JP2017524768A (ja) * 2014-08-01 2017-08-31 マサチューセッツ インスティテュート オブ テクノロジー 抗線維化材料のための修飾されたアルギネートおよび用途
JP2018534297A (ja) * 2015-10-29 2018-11-22 ノバルティス アーゲー toll様受容体アゴニストを含む抗体コンジュゲート
US20190192668A1 (en) * 2017-12-26 2019-06-27 Kymera Therapeutics, Inc. Irak degraders and uses thereof
WO2019195055A1 (en) * 2018-04-04 2019-10-10 Sigilon Therapeutics, Inc. Implantable particles and related methods
JP2019529579A (ja) * 2016-10-03 2019-10-17 シギロン セラピューティクス, インコーポレイテッドSigilon Therapeutics, Inc. 化合物、デバイスおよびその使用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2411197A (en) * 1996-04-30 1997-11-19 Affymax Technologies N.V. Methods for the synthesis of fmoc protected amines
US20180185368A1 (en) * 2014-11-06 2018-07-05 Lysosomal Therapeutics Inc. Substituted pyrrolo[1,2-a]pyrimidines and their use in the treatment of medical disorders

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012514009A (ja) * 2008-12-31 2012-06-21 アーデリクス,インコーポレーテッド 体液貯留または塩分過負荷と関連する障害および消化管障害の治療におけるnhe媒介性アンチポートを阻害するための組成物および方法
JP2017524768A (ja) * 2014-08-01 2017-08-31 マサチューセッツ インスティテュート オブ テクノロジー 抗線維化材料のための修飾されたアルギネートおよび用途
WO2016071856A1 (en) * 2014-11-06 2016-05-12 Novartis Ag Amatoxin derivatives and conjugates thereof as inhibitors of rna polymerase
JP2018534297A (ja) * 2015-10-29 2018-11-22 ノバルティス アーゲー toll様受容体アゴニストを含む抗体コンジュゲート
JP2019529579A (ja) * 2016-10-03 2019-10-17 シギロン セラピューティクス, インコーポレイテッドSigilon Therapeutics, Inc. 化合物、デバイスおよびその使用
US20190192668A1 (en) * 2017-12-26 2019-06-27 Kymera Therapeutics, Inc. Irak degraders and uses thereof
WO2019195055A1 (en) * 2018-04-04 2019-10-10 Sigilon Therapeutics, Inc. Implantable particles and related methods

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
"CAS REGISTRY No. 2419398-88-0", DATABASE REGISTRY [ONLINE], JPN7025002082, 2020, pages 2025 - 04, ISSN: 0005592381 *
HOWARTH, N. M. ET AL.: ""Synthesis of N-propynyl analogues of peptide nucleic acid (PNA) monomers and their use in the clic", TETRAHEDRON, vol. 67, no. 49, JPN6025019114, 2011, pages 9588 - 9594, ISSN: 0005592379 *
LU, G. ET AL.: ""An iterative route to "decorated" ethylene glycol-based linkers"", CHEMICAL COMMUNICATIONS, JPN6025019112, 2006, pages 1652 - 1654, ISSN: 0005592377 *
MARRA, A. ET AL.: ""Copper(I)-Catalyzed Azide-Alkyne Cycloadditions in Ionic Liquids under Amine-Free Conditions"", SYNTHESIS, vol. 2010, no. 12, JPN6025019113, 2010, pages 2043 - 2048, ISSN: 0005592378 *
TEKKAM, S. ET AL.: ""Synthesis and Reactivity of 5-Substituted Furfuryl Carbamates via Oxanorbornadienes"", ORGANIC LETTERS, vol. 19, no. 11, JPN6025019115, 2017, pages 2833 - 2836, ISSN: 0005592380 *

Also Published As

Publication number Publication date
WO2022031862A2 (en) 2022-02-10
BR112023002132A2 (pt) 2023-04-11
KR20230048523A (ko) 2023-04-11
US20230303502A1 (en) 2023-09-28
EP4192468A4 (en) 2024-09-11
WO2022031862A3 (en) 2022-03-24
CA3190778A1 (en) 2022-02-10
EP4192468A2 (en) 2023-06-14
AU2021321433A1 (en) 2023-03-02
CN116322777A (zh) 2023-06-23

Similar Documents

Publication Publication Date Title
KR20230048523A (ko) 헤테로아릴 및 헤테로사이클릴 화합물
JP7199739B2 (ja) Gabaaの正のアロステリックモジュレーターの塩及び結晶形態
JP2021521163A (ja) 標的タンパク質分解化合物、その抗腫瘍応用、その中間体および中間体の応用
JP6148594B2 (ja) E1活性化酵素阻害剤の合成のためのプロセス
AU2020350529B2 (en) Cyano-substituted cyclic hydrazine derivative and application thereof
TWI921403B (zh) 雙環1,4-二氮雜環庚酮及其治療用途
US20250376432A1 (en) Process for preparing modulators of eukaryotic initiation factor 2b
JP2026516129A (ja) Wee1-Yes二重標的阻害剤としてのピリミドマクロ複素環式化合物及びその応用
CN104619702A (zh) Ccr2的稠合环戊基拮抗剂
JP2022507361A (ja) オレキシン受容体調節因子としての縮合複素環式化合物を作製する改良された合成方法
Kumar et al. Sacrificial azomethine ylide cycloaddition controlled chemoselective nitrile oxide cycloaddition to 1-methyl-3, 5-bis [(E)-arylmethylidene] tetrahydro-4 (1H)-pyridinones: formation of mono-spiro-isoxazolines
KR20180128907A (ko) 면역조절제로서 작용하는 트리시클릭 화합물 (tricyclic compound serving as immunomodulator)
JP6940480B2 (ja) Fgfr阻害剤の合成方法
CA3163920A1 (en) Tetrahydrobenzo-quinoline sulfonamides derivative compounds
JP2022531936A (ja) イミダゾ[1,2-a]ピリミジンの位置選択的合成
ES2977277T3 (es) Procesos para preparar (3R,4R)-1-bencil-n,4-dimetilpiperidin-3-amina o una de sus sales y procesos para preparar tofacitinib mediante el uso de la misma
Huszthy et al. Efficient synthesis of azetidine through N‐trityl‐or N‐dimethoxytritylazetidines starting from 3‐amino‐l‐propanol or 3‐halopropylamine hydrohalides
JP2025030529A (ja) 重水素化化合物の製造方法
Sheldrick et al. 5-Ethoxycarbonyl-3, 4'-diethyl-4, 3', 5'-trimethyl-2, 2'-dipyrrolyl ketone
JPH05186437A (ja) 縮合ピリミジン誘導体
Jaskólski et al. Synthesis and crystal and molecular structure of 1, 2-Di (N-piperidyl) ethane-bis-N-oxide tetrahydrate
WO2017108927A1 (en) Process for preparation of ingenol 3-(3.5-diethylisoxazole-4-carboxylate)
JPH0321609A (ja) 有機ホウ素含有ポリマー
JPS58124719A (ja) 抗腫瘍剤
Wang Syntheses and characterizations of new polymers with bile acid derivatives as pendant groups

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20230317

RD01 Notification of change of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7426

Effective date: 20230317

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240805

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240805

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250513

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20250515

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20250812

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251010

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20251209

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260408

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20260529

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20260601